FDA Works To Encourage Office-Use Compounding Under 503B In Advance Of Legislation 26 Sep 2017

FDA Works To Encourage Office-Use Compounding In Advance Of ...

https://pink.pharmamedtechbi.com/.../fda-works-to-encourage-officeuse-compoundin...

9 hours ago - FDA looks to carve out a place for office-use compounding within Section 503B, the new framework created after deadly fungal contamination of products, while ...